TITLE

Rx: Inexpensive Pills With Costly Labels

AUTHOR(S)
Ognibene, Peter J.
PUB. DATE
June 1973
SOURCE
New Republic;6/2/73, Vol. 168 Issue 22, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents information on the escalating cost of medicines in the U.S. Impact of inflation on the cost of medicines in the U.S.; Study of the prescription drug industry by Senator Gaylord Nelson and Congressman Ben Rosenthal; Opinion that U.S. consumers are forced to pay over a billion dollars annually in unnecessary prescription drug costs because of prohibitions on retail advertising, over-protective patent laws, exorbitant promotional expenditures by industry and unreasonable markups; Information on the fact that the drug industry spends more than $1 billion a year in advertising and other promotional campaigns; View that the drug industry spends an average of about $5000 per doctor to convince them to prescribe brand name products; Suggestions for consumers to cut down on their prescription costs.
ACCESSION #
10152091

 

Related Articles

  • Perspective on government-funded innovations. Ancker-Johnson, Betsy // Physics Today;Apr78, Vol. 31 Issue 4, p96 

    Editorial. Focuses on the rights to inventions developed with federal funding in the U.S. Legislation on patent policy introduced by Congressman Ray Thornton; Reasons for not using inventions; Views of Senator Gaylord Nelson on federally funded inventions.

  • Send Lawyers, Guns, and Money: My Patent Has Hit the Fan.  // BioPharm International;Jun2005, Vol. 18 Issue 6, p26 

    Focuses on the cultural significance of the increasing dependency on prescription drugs in the U.S. Collision course of generic drugs with various patent protection initiatives that protect brand name prescription drug developers; Lobbying of the biopharmaceutical sector for patent rights laws,...

  • Pharmaceutical patent challenges--time for reassessment? Glass, Gregory // Nature Reviews Drug Discovery;Dec2004, Vol. 3 Issue 12, p1057 

    For nearly 15 years after the passage of the Hatch-Waxman Act in 1984, generics drug companies took little advantage of its provisions, which provided financial incentives to them for challenging the patents of branded pharmaceutical products. However, during the past 3-5 years, generics...

  • Honor the earth. Wilkinson, R. // Mother Jones;Apr/May90, Vol. 15 Issue 3, p12 

    Profiles Gaylord Nelson, former Senator of Wisconsin and founder of Earth Day which is celebrating its 20th anniversary this year. Childhood; Political career; Efforts to make the environment a significant issue; Thoughts on the past 20 years of environmentalism.

  • A Fond Farewell to the Father of Earth Day.  // Wilderness;Dec2005/2006, p59 

    The article presents an obituary for Gaylord Nelson, founder of Earth Day event.

  • NAME THAT BRAND.  // Medical Marketing & Media;Aug2004, Vol. 39 Issue 8, p112 

    Presents several clues to the identity of the mystery brand based on the print advertising of the pharmaceutical products.

  • Rx Branding. Hallahan, Mary; Madell, Robin // Pharmaceutical Executive;Nov99, Vol. 19 Issue 11, p98 

    Advises on how up-and-coming marketers should prepare for the new age of pharmaceutical branding and brand management. Significance of branding in the pharmaceutical business; Challenge in choosing a good name; Image creation which elicits positive reception; Forecasts on pharmaceutical branding...

  • Understanding brand loyalty.  // Prevention India;Jan2011, p15 

    The article discusses the status of pharma manufacturers and medicines in India. It has been stated that same medicine in India is sold under various brand names and prices of different brands significantly varies. It has been stated that more expensive brands are often prescribed by doctors due...

  • TOP STORIES.  // MondayMorning;3/10/2008, Vol. 16 Issue 10, p1 

    Monday, March 10, 2008 / Vol. 16 / No. 10 MondayMorning Weekly Online News Update for the Healthcare Industry Monday, March 10, 2008 / Vol. 16 / No. 10 ©2008 MedContent, Inc / All Rights Reserved TOP STORIES Brand-Name Drugs Continue Sharp Price Increases. Drugmakers increased their...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics